NEW YORK (GenomeWeb) – CareDx today announced that two Medicare Administrative Carrier jurisdictions have issued positive decisions on covering its AlloMap molecular diagnostic surveillance test for heart transplant patients, extending coverage to Medicare patients in 11 additional states.

Four of the 12 MAC jurisdictions now cover the test. The newly affected states are Ohio, Kentucky, Oregon, Washington, Arizona, Utah, Idaho, Montana, North Dakota, South Dakota, and Wyoming.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.